港股IPO入门:新手如何参与新股申购? November 6, 2026

港股IPO入门:新手如何参与新股申购?

在香港资本市场中,首次公开募股(Initial Public Offering, IPO)一直是投资者关注度较高的投资机会之一。每年,香港交易及结算都会迎来数十家新股上市,行业覆盖科技、消费、医疗健康以及工业等多个板块。对于许多刚接触港股市场的投资者来说,新股申购不仅是了解市场的重要入口,也可能带来短期收益或长期投资机会。


(1) 什么是IPO?

港股IPO入门:新手如何参与新股申购?

IPO指的是公司首次向公众投资者发行股票并在证券交易所上市交易。通过上市,公司可以向市场募集资金,用于业务扩展、研发投入或债务优化等。在企业上市时,股份通常分为两部分,即是面向散户投资者的公开发售和面向机构投资者的国际配售。


(2) 如何开始申购港股IPO?

港股IPO入门:新手如何参与新股申购?


投资者可按照以下步骤申购港股 IPO:

  1. 开设证券账户

港股IPO入门:新手如何参与新股申购?

新加坡辉立证券提供线上开户。投资者需要先开通证券账户,完成入金,提交相关港股IPO申购表格后才能开始申购。


  1. 查看新股发行信息

港股IPO入门:新手如何参与新股申购?

每当有公司计划上市时,市场会公布招股书、发行价区间、申购时间以及预计上市日期。

点击以下链接查看港股IPO详情:http://www.poems.com.hk/en-us/product-and-service/initial-public-offerings/ipo-info/#Scheduled


  1. 提交申购申请

港股IPO入门:新手如何参与新股申购?

在招股期内,投资者可以通过券商提交申购申请。

您可以通过POEMS 2.0 网页版,使用您的POEMS账户认购香港新股(IPO)。

登录POEMS 网页版 → 账户管理 → 股票 → 在线表格 → 账户申请 → IPO 新股认购 – 在线不可撤销表格

港股IPO入门:新手如何参与新股申购?

如需手动处理申购表格,请联系您指定的交易员。


  1. 等待配售结果

港股IPO入门:新手如何参与新股申购?

IPO配售结果是由发行方决定。若投资者成功中签,获配金额和相关费用将会从交易账户扣除以完成认购;若申购者未能中签或部分中签,未使用资金将会在扣除相关费用之后退回至交易账户。


  1. 上市交易

港股IPO入门:新手如何参与新股申购?

中签的投资者可以通过辉立证券,在新股上市前一天在香港IPO暗盘,或于在上市后在香港交易所进行买卖。
注:并非所有香港新股都有暗盘交易,只有在香港主板上市的新股才会进行暗盘交易。

更多香港IPO暗盘详情,可浏览: https://tinyurl.com/mr3fbf5f


(3) 新股申购的常见策略

港股IPO入门:新手如何参与新股申购?

对于新手投资者而言,参与港股IPO时可以关注以下关键因素:

  • 公司基本面:包括行业前景、盈利能力及商业模式。
  • 发行估值:对比同类型上市公司的市盈率或估值水平。
  • 市场情绪:热门行业或明星企业往往认购热度较高。


(4) 需要注意的风险

港股IPO入门:新手如何参与新股申购?

尽管部分新股上市后表现亮眼,但需注意的是IPO并非稳赚不赔。新股上市后也可能出现破发(即股价跌破发行价)的情况。因此,投资者在参与申购IPO时应注意:

风险定义说明
配售风险热门IPO往往出现超额认购,可能仅分配少量的股份,甚至无法获得配售
市场风险新股上市后股价可能低于发行价,从而带来资本亏损
杠杆风险通过融资申购将放大收益与损失,投资者可能面临超过初始投入的亏损
汇率风险涉及不同货币兑换时,需承担汇率波动带来的不确定性
流动性风险在市场波动或压力的情况下,投资者可能无法以理想的价格或时机卖出获配股

(5) 专业投资者专属认购方案

专业投资者(Accredited Investors,AIs)可选择通过股票融资方式认购香港新股,以降低认购所需的初始现金投入,无需一次性支付全部认购金额

  • 低门槛自付资金:仅需支付认购金额的20%,其余80%可通过融资支付,且融资部分免收利息。
  • 灵活认购额度:认可投资者(AIs)可获准以低于S$200,000的金额进行认购。
  • 认购手续费豁免:HK$100认购手续费目前豁免,直至另行通知。


如不选择融资方式,专业投资者也可选择以全额现金认购香港新股。如需了解申请流程及资格要求,请联系您的指定交易代表或交易团队。


点击了解港股申购指南


开户无国界,无开户费用,无最低押金

港股IPO入门:新手如何参与新股申购?

港股IPO入门:新手如何参与新股申购?

点击了解港股

港股IPO入门:新手如何参与新股申购?


如果您想进一步了解港股投资,也可以参考以下内容:

点击了解 港股暗盘交易

点击了解 港股IPO申购指南

新手必看!港股暗盘交易全攻略 教您如何轻松提前买卖新股,抓住赚取首日红利的机会


投资有疑问?来聊聊吧!

如果您对港股投资还有疑问,欢迎找我们聊一聊。

可以通过微信、WhatsApp、电话或邮件联系,我们的中文团队会为您提供协助。

无论是开户、交易流程,还是其他投资相关问题,都可以直接咨询。

 

联系方式

微信 | PSPLSG
WhatsApp | (65) 8800 7686
电话 | (65) 6531 1264
邮件 | GMD_China@phillip.com.sg
微信服务号:新加坡辉立环球

 

为什么很多投资者选择辉立证券?

  • 一个账户,交易 26个国家及地区股票
  • 超过 40,000种投资产品
  • 全中文交易界面
  • 专业中文客服与交易团队
  • 开户流程简单、交易成本具竞争力

 


免责声明

本文仅供一般性传播之用,并未考虑任何人士的特定投资目标、财务状况或个别需要。因此,对于任何人士因直接或间接依据本资料行事而导致的任何损失,概不作出任何保证,亦不承担任何责任。在作出任何投资承诺前,您应根据自身的投资目标、财务状况及个别需要,就本文所提及的任何投资产品是否适合您,向财务顾问寻求意见。

本文所载观点如有变更,恕不另行通知。投资涉及风险,包括可能损失全部或部分本金。任何基金单位的价值及其收益可能下跌亦可能上升。本文所引用的过往表现数据以及任何预测或展望,并不必然代表未来或潜在表现。

辉立证券私人有限公司(Phillip Securities Pte Ltd,简称 PSPL)及其董事、关联人士或雇员,可能不时在本文所提及的金融工具中拥有权益。

本文所载资料取自公共来源,PSPL并无理由相信该等来源不可靠。文中所包含的任何分析、预测、推算、预期及观点(统称“研究内容”)均基于该等资料,仅属信念表达。PSPL并未核实有关资料,亦未就该等资料或研究内容的准确性、完整性或已获核实作出任何明示或暗示的陈述或保证,亦不应据此加以依赖。相关资料及研究内容可能随时变更,PSPL无义务维持、更新或更正已提供的资料或研究内容。在任何情况下,即使已被告知可能发生有关损害,PSPL亦不对因使用该等资料或研究内容而产生的任何特殊、间接、附带或后果性损害承担责任。本文所提及的公司及其雇员,亦不对任何因任何原因造成的错误、不准确或遗漏承担责任。本文所载任何意见或建议均属一般性质,并可在不另行通知的情况下变更。本文所提供的信息可能包含有关国家、市场或公司未来事件或未来财务表现的乐观陈述,您须自行评估本文信息的相关性、准确性及充分性。

本文所表达的观点及任何投资策略未必适合所有投资者,且本文所载意见可能与 PSPL其他部门或其关联人士、联营机构所表达的意见不同。本文中对任何投资产品或商品的提及或讨论仅作说明用途,不应被视为任何推荐、要约或邀请,以进行相关投资产品或商品的认购、购买或出售。

本广告未经新加坡金融管理局审阅。

关于作者

Mee Yi Ting
辉立证券环球交易部中文资深交易员

Mee Yi 是辉立证券环球交易部中文团队的资深交易员。她主要负责分析股市信息和执行交易。她毕业于澳洲斯威本理工大学,拥有市场营销学学士学位。她曾在马来西亚辉立资本工作,作为持牌衍生品交易员和营销专员。

No Related Market Journal.

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com